Bioelife logo

LITH - Bioelife Share Price

$0.22 0.0  0.0%

Last Trade - 01/06/20

Sector
Healthcare
Size
Micro Cap
Market Cap £1.68m
Enterprise Value £1.66m
Revenue £n/a
Position in Universe 5956th / 6356
Bullish
Bearish
Unlock LITH Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the nine months ended 30 September 2019, Bioelife Corp revenues was not reported. Net loss totaled $74K vs. income of $178K. Net loss reflects Gain on sale of mineral property decrease from $675K (income) to $0K, General and administrative increase from $9K to $21K (expense), Professional fees increase of 16% to $29K (expense). Basic Earnings per Share excluding Extraordinary Items decreased from $0.07 to -$0.02.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

LITH Revenue Unlock LITH Revenue

Net Income

LITH Net Income Unlock LITH Revenue

Normalised EPS

LITH Normalised EPS Unlock LITH Revenue

PE Ratio Range

LITH PE Ratio Range Unlock LITH Revenue

Dividend Yield Range

LITH Dividend Yield Range Unlock LITH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
LITH EPS Forecasts Unlock LITH Revenue
Profile Summary

BioELife Corp., formerly U.S. Lithium Corp., is engaged in cannabidiol (CBD) business. The Company’s products include combo adult gummies with chirorub, combo tincture with chirorub, intensive relief rub, tinctures, adult gummies, premium pre-rolls and flower. The Company has also developed a 3 milliliter (ml) packaging option for single use applications. The Company serves wholesale, retail and consumer channels.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated November 2, 2006
Public Since January 29, 2009
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange OTC Markets Group
Shares in Issue 9,409,970
Free Float (0.0%)
Eligible for
ISAs
SIPPs
LITH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for LITH
Upcoming Events for LITH
Frequently Asked Questions for Bioelife
What is the Bioelife share price?

As of 01/06/20, shares in Bioelife are trading at $0.22, giving the company a market capitalisation of £1.68m. This share price information is delayed by 15 minutes.

How has the Bioelife share price performed this year?

Shares in Bioelife are currently trading at $0.22 and the price has moved by -15.38% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bioelife price has moved by -17.59% over the past year.

What are the analyst and broker recommendations for Bioelife?

There are no analysts currently covering Bioelife.

When will Bioelife next release its financial results?

Bioelife is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-09-30
What is the Bioelife dividend yield?

Bioelife does not currently pay a dividend.

Does Bioelife pay a dividend?

Bioelife does not currently pay a dividend.

When does Bioelife next pay dividends?

Bioelife does not currently pay a dividend.

How do I buy Bioelife shares?

To buy shares in Bioelife you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Bioelife?

Shares in Bioelife are currently trading at $0.22, giving the company a market capitalisation of £1.68m.

Where are Bioelife shares listed? Where are Bioelife shares listed?

Here are the trading details for Bioelife:

Country of listing: United States
Exchange: OTC
Ticker Symbol: LITH
What kind of share is Bioelife?

Based on an overall assessment of its quality, value and momentum, Bioelife is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Bioelife share price forecast 2020?

We were not able to load any forecast data for Bioelife.

How can I tell whether the Bioelife share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioelife. Over the past six months, the relative strength of its shares against the market has been -24%. At the current price of $0.22, shares in Bioelife are trading at -53.81% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Bioelife PE Ratio?

We were not able to find PE ratio data for Bioelife.

Who are the key directors of Bioelife?

Bioelife's management team is headed by:

Eric Allison - DRC
Gregory Rotelli - PRE
Who are the major shareholders of Bioelife?

Here are the top five shareholders of Bioelife based on the size of their shareholding:

Ravenhill International Holdings Corporation
Percentage owned: 9.67% (910k shares)
Hall (Simon Kenneth) Individual Investor
Percentage owned: 9.67% (910k shares)
Windward International, L.L.C. Corporation
Percentage owned: 9.63% (906k shares)
Marciniak (William) Individual Investor
Percentage owned: 7.17% (675k shares)
Olive Green Holdings Ltd Corporation
Percentage owned: 4.99% (470k shares)
Similar to LITH
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.